PUBLISHER: The Business Research Company | PRODUCT CODE: 1712394
PUBLISHER: The Business Research Company | PRODUCT CODE: 1712394
Defibrillator devices and equipment are essential for addressing critical cardiac arrhythmias and irregular heart rhythms in emergency situations, delivering high-energy electrical shocks to restore normal heart function.
Within the defibrillator market, the primary device categories encompass implantable defibrillators and external defibrillators. Implantable defibrillators are small, battery-powered devices strategically placed within the body to detect and correct irregular heartbeats. This category includes various types such as transvenous implantable cardioverter-defibrillators (T-ICDs), subcutaneous implantable cardioverter-defibrillators (S-ICDs), and cardiac resynchronization therapy-defibrillators (CRT-Ds), available as single or dual chamber devices. Meanwhile, external defibrillators consist of manual external defibrillators (MEDs), automated external defibrillators (AEDs), and wearable cardioverter defibrillators (WCDs). These devices cater to multiple end-users, including hospitals, pre-hospital emergency services, the public access market, alternate care facilities, and home healthcare setups.
The defibrillator devices and equipment market research report is one of a series of new reports from The Business Research Company that provides defibrillator devices and equipment market statistics, including defibrillator devices and equipment industry global market size, regional shares, competitors with a defibrillator devices and equipment market share, detailed defibrillator devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the defibrillator devices and equipment industry. This defibrillator devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The defibrillator devices and equipment market size has grown strongly in recent years. It will grow from $12.17 billion in 2024 to $13.22 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to cardiac arrest prevalence, aging population, emergency medical services (ems) integration, public awareness and training.
The defibrillator devices and equipment market size is expected to see strong growth in the next few years. It will grow to $16.2 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to personalized medicine, telehealth integration, global access to healthcare, bystander intervention and public access defibrillation. Major trends in the forecast period include wearable defibrillators, next-generation aeds, subcutaneous icds (s-icds), pediatric defibrillation.
The expected rise in healthcare expenditure is anticipated to drive the expansion of the defibrillator devices and equipment market in the foreseeable future. Healthcare expenditure encompasses spending on various healthcare goods and services, including personal health care, public health activities, health research, and insurance programs. Increased healthcare expenditure is likely to contribute to the higher adoption of defibrillator devices across healthcare facilities and public access defibrillation programs. For instance, according to the National Health Expenditure Account (NHEA) published by the Centers for Medicare and Medicaid Services, a US-based federal agency, U.S. healthcare spending increased by 4.1% in 2022, reaching $4.5 trillion or $13,493 per person. Health spending accounted for 17.3% of the nation's Gross Domestic Product. This enhanced healthcare infrastructure is contributing to the growth of the defibrillator devices and equipment market.
The increasing occurrence of sudden cardiac arrest (SCA) stands as a significant driver for the defibrillator devices and equipment market. As reported by the American Heart Association (AHA), the annual incidence of SCA among individuals of any age approximates 356,461 cases. SCA is marked by the complete cessation of cardiac activity, and defibrillators are instrumental in delivering a therapeutic shock to revive the patient's heartbeat. This pivotal role in resuscitation contributes to the projected growth of the defibrillator market.
Major companies in the defibrillator devices and equipment market are focused on innovating new products, such as the Avive AED, aimed at enhancing survival rates. Avive AED stands out as the most compact and lightweight FDA-approved Automated External Defibrillator (AED) available, emphasizing accessibility, portability, and resilience. In January 2023, Avive Solutions Inc., a manufacturer of portable defibrillators based in the United States, secured pre-market approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Avive Connect AED. This device is designed for easy placement in various settings, with optimized connectivity, rigorously tested for user-friendliness, and harnesses cellular and WiFi connectivity, GPS technology, remote maintenance, and exceptional portability in a handheld AED.
Leading companies in the defibrillator devices and equipment market are focusing on developing innovative products, such as advanced defibrillators, to enhance patient outcomes and improve device functionality. Advanced defibrillators are medical devices designed to deliver electric shocks to the heart in cases of life-threatening arrhythmias, such as ventricular fibrillation or sudden cardiac arrest. For example, in June 2024, Stryker Healthcare, a US-based medical technology company, introduced the LIFEPAK 35 monitor/defibrillator. This device is designed to improve emergency medical care with its intuitive, lightweight design and a large touchscreen for customizable clinical workflows. Equipped with connected capabilities for continuous patient data monitoring, the LIFEPAK 35 addresses challenges faced by healthcare providers, including staff shortages and mental health concerns. Developed based on over a decade of research and feedback from healthcare professionals, it underscores Stryker's dedication to providing reliable tools for first responders and healthcare workers, ensuring consistent, high-quality care from roadside emergencies to hospital settings.
Major companies operating in the defibrillator devices and equipment market include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V, ZOLL Medical Corporation, Cardiac Science Corporation, Physio-Control Inc., Nihon Kohden Corporation, Defibtech LLC, Schiller AG, Biotronik Inc., LivaNova PLC, HeartSine Technologies LLC, Mindray Medical International Limited, Metrax Engineering Ltd., CU Medical Systems Inc., Fukuda Denshi Co. Ltd., GE Healthcare, Innomed Technologies Inc., Progetti Srl, Stryker Corporation, Welch Allyn Inc., Weinmann Emergency Medical Technology GmbH + Co. KG, Bexen Cardio, GCE Group, Lepu Medical Technology (Beijing) Co. Ltd., Shenzhen XFT Medical Limited, Zhejiang Medtec Medical Devices Co. Ltd.
North America was the largest region in the global defibrillator devices and equipment market in 2024. Western Europe was the second-largest region in the defibrillator devices and equipment market. The regions covered in the defibrillator devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the defibrillator devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The defibrillator devices and equipment market consist of sales of instruments such as manual external defibrillator, implantable cardioverter defibrillator, manual internal defibrillator, automated external defibrillator, and wearable defibrillators. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Defibrillator Devices And Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on defibrillator devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for defibrillator devices and equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The defibrillator devices and equipment market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.